1-20 of 46
Sushil Kumar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3526: GAIN-BRCA: A graphical explainable AI-net framework for breast cancer subtype classification using multiomics data

Jai Chand Patel, Sushil Kumar Shakyawar, Sahil Sethi, Chittibabu Guda
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3526.
https://doi.org/10.1158/1538-7445.AM2024-3526
Published: 22 March 2024
View article titled, Abstract 3526: GAIN-BRCA: A graphical explainable AI-net framework for breast cancer subtype classification using multiomics data
Journal Articles

Abstract 1594: Pancreatic cancer and T-cell crosstalk-induced MUC4 expression attenuates T-cell-mediated response

Xiaoqi Li, Imran Khan, Rachel Kehrberg, Zahraa Wajih Alsafwani, Rakesh Bhatia, Sushil Kumar, Surinder K. Batra
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1594.
https://doi.org/10.1158/1538-7445.AM2024-1594
Published: 22 March 2024
View article titled, Abstract 1594: Pancreatic cancer and T-cell crosstalk-induced MUC4 expression attenuates T-cell-mediated response
Journal Articles

Abstract A014: Combinations of previously reported biomarkers achieve improved sensitivity and specificity of detection of early stage pancreatic ductal adenocarcinoma

Brian Haab, Lu Qian, Ben Staal, Maneesh Jain, Johannes Fahrmann, Christine Worthington, Denise Prosser, Liudmila Velokokhatnaya, Camden Lopez, Runlong Tang, Mark Hurd, Gopalakrishnan Natarajan, Sushil Kumar, Lynette Smith, Samir Hanash, Surinder Batra, Anirban Maitra, Anna Lokshin, Ying Huang, Randall E. Brand, Liudmila Velokokhatnaya
Journal: Cancer Research
Cancer Res (2024) 84 (2_Supplement): A014.
https://doi.org/10.1158/1538-7445.PANCA2023-A014
Published: 16 January 2024
View article titled, Abstract A014: Combinations of previously reported biomarkers achieve improved sensitivity and specificity of detection of early stage pancreatic ductal adenocarcinoma
Journal Articles

Abstract 3247: Combination therapy using PERK and PD1/PD-L1 inhibitors reprograms tumor associated macrophages and reduces tumor burden

Sushil Kumar, Michael McCane, Jeremy Drees, Nandita Bose, Lisa Coussens
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3247.
https://doi.org/10.1158/1538-7445.AM2023-3247
Published: 04 April 2023
View article titled, Abstract 3247: Combination therapy using PERK and PD1/PD-L1 inhibitors reprograms tumor associated macrophages and reduces tumor burden
Journal Articles

Abstract 1133: A B7-H4 targeting antibody-drug conjugate shows anti-tumor activity in PARPi and platinum resistant cancers with B7-H4 expression

Sarah B. Gitto, Margaret Whicker, Gareth Davies, Sushil Kumar, Krista Kinneer, Arthur Lewis, Srinivas Mamidi, Sergey Medvedev, Judith Anderton, Jessica Tang, Benjamin Ferman, Steve Coats, Robert W. Wilkinson, Eric J. Brown, Daniel J. Powell, Fiona Simpkins
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1133.
https://doi.org/10.1158/1538-7445.AM2023-1133
Published: 04 April 2023
View article titled, Abstract 1133: A B7-H4 targeting antibody-drug conjugate shows anti-tumor activity in PARPi and platinum resistant cancers with B7-H4 expression
Journal Articles

Abstract 554: The role of Mycobacterium w as a novel treatment for osteosarcoma

Kirsten Stefan, Arpit Dheeraj, Dhanir Tailor, Sushil Kumar, Wenqi Li, Rajiv Modi, Manjul Joshipura, Bakulesh Khamar, Lara E. Davis, Sanjay V. Malhotra
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 554.
https://doi.org/10.1158/1538-7445.AM2023-554
Published: 04 April 2023
View article titled, Abstract 554: The role of <em>Mycobacterium w</em> as a novel treatment for osteosarcoma
Journal Articles

Abstract 3473: High throughput screening of combination therapies to improve response to checkpoint inhibitors in solid tumors using a myelomonocytic and T cell co-culture assay

Sushil Kumar, Dhanir Tailor, Arpit Dheeraj, Wenqi Li, Jee Min Lee, Kirsten Stefan, Dylan Nelson, Shivaani Kummar, Lisa M. Coussens, Sanjay V. Malhotra
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3473.
https://doi.org/10.1158/1538-7445.AM2023-3473
Published: 04 April 2023
View article titled, Abstract 3473: High throughput screening of combination therapies to improve response to checkpoint inhibitors in solid tumors using a myelomonocytic and T cell co-culture assay
Journal Articles

Abstract A027: Identification and role of mega-trans-factors in epithelial ovarian cancer

Sushil Kumar Jaiswal, Kevin Fedkenheuer, Laura Elnitski
Journal: Cancer Research
Cancer Res (2022) 82 (23_Supplement_2): A027.
https://doi.org/10.1158/1538-7445.CancEpi22-A027
Published: 01 December 2022
View article titled, Abstract A027: Identification and role of mega-trans-factors in epithelial ovarian cancer
Journal Articles

Abstract 603: Discovery of CD200R1 as a novel immuno-oncology target using pleiotropic signals from 23andMe’s genetic and health survey database

Xin Fang, Wei-Jen Chung, Jill Fenaux, Alice Chen, Nizar Batada, Maike Schmidt, Sophia R. Majeed, Sushil Kumar, Steven Pitts
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 603.
https://doi.org/10.1158/1538-7445.AM2022-603
Published: 15 June 2022
View article titled, Abstract 603: Discovery of CD200R1 as a novel immuno-oncology target using pleiotropic signals from 23andMe’s genetic and health survey database
Journal Articles

Abstract 602: 23ME-00610 is a first-in-class monoclonal antibody that targets the CD200R1 immune checkpoint to enhance T cell-mediated antitumor activity

Jill Fenaux, Yao-ming Huang, Cristina Melero, Wei-Jen Chung, Suk Lee, Dina Ayupova, Mauro Poggio, Dylan Glatt, Zuoan Yi, Cecilia Lay, Maike Schmidt, Sophia R. Majeed, Germaine Fuh, Alice Chen, Sushil Kumar
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 602.
https://doi.org/10.1158/1538-7445.AM2022-602
Published: 15 June 2022
View article titled, Abstract 602: 23ME-00610 is a first-in-class monoclonal antibody that targets the CD200R1 immune checkpoint to enhance T cell-mediated antitumor activity
Journal Articles

Abstract 716: Silibinin: A novel potential therapeutic agent against UVB-induced basal cell carcinoma

Komal Raina, Sandeep Paudel, Neha Mishra, Sushil Kumar, David J. Orlicky, Zhiying You, Rama Kant, Chapla Agarwal, Rajesh Agarwal
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 716.
https://doi.org/10.1158/1538-7445.AM2022-716
Published: 15 June 2022
View article titled, Abstract 716: Silibinin: A novel potential therapeutic agent against UVB-induced basal cell carcinoma
Journal Articles

Abstract 2137: Differential gene expression identifies a transcriptional regulatory network involving ESR1and PITX1 in invasive epithelial ovarian cancer

Yichao Li, Sushil Kumar Jaiswal, Rupleen Kaur, Dana Alsaadi, Xiaoyu Liang, Frank Drews, Julie A. DeLoia, Thomas Krivak, Hanna M. Petrykowska, Valer Gotea, Lonnie Welch, Elnitski Laura
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2137.
https://doi.org/10.1158/1538-7445.AM2021-2137
Published: 01 July 2021
View article titled, Abstract 2137: Differential gene expression identifies a transcriptional regulatory network involving ESR1and PITX1 in invasive epithelial ovarian cancer
Journal Articles

Estrogen Receptor β-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast Cancer

Christoforos Thomas, Ilias V. Karagounis, Ratnesh K. Srivastava, Nicholas Vrettos, Fotis Nikolos, Noëlle Francois, Menggui Huang, Siliang Gong, Qi Long, Sushil Kumar, Constantinos Koumenis, Savitri Krishnamurthy, Naoto T. Ueno, Rumela Chakrabarti, Amit Maity
Journal: Cancer Research
Cancer Res (2021) 81 (9): 2399–2414.
https://doi.org/10.1158/0008-5472.CAN-20-2743
Published: 01 May 2021
View article titled, Estrogen Receptor β-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast Cancer
Open the PDF for Estrogen Receptor β-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity

Viralkumar Davra, Sushil Kumar, Ke Geng, David Calianese, Dhriti Mehta, Varsha Gadiyar, Canan Kasikara, Kevin C. Lahey, Yun-juan Chang, Michael Wichroski, Chan Gao, Mariana S. De Lorenzo, Sergei V. Kotenko, Tessa Bergsbaken, Pankaj K. Mishra, William C. Gause, Michael Quigley, Thomas E. Spires, Raymond B. Birge
Journal: Cancer Research
Cancer Res (2021) 81 (3): 698–712.
https://doi.org/10.1158/0008-5472.CAN-20-2066
Published: 01 February 2021
View article titled, Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity
Open the PDF for Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity in another window
Includes: Supplementary data
Journal Articles

Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness

Koelina Ganguly, Shiv Ram Krishn, Satyanarayana Rachagani, Rahat Jahan, Ashu Shah, Palanisamy Nallasamy, Sanchita Rauth, Pranita Atri, Jesse L. Cox, Ramesh Pothuraju, Lynette M. Smith, Sudhua Ayala, Christopher Evans, Moorthy P. Ponnusamy, Sushil Kumar, Sukhwinder Kaur, Surinder K. Batra
Journal: Cancer Research
Cancer Res (2021) 81 (1): 91–102.
https://doi.org/10.1158/0008-5472.CAN-20-1293
Published: 04 January 2021
View article titled, Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness
Open the PDF for Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness in another window
Includes: Supplementary data
Journal Articles

Abstract PD7-02: Estrogen receptor β suppresses metastasis of inflammatory breast cancer by regulating signaling that promotes cytoskeleton remodeling

Christoforos Thomas, Ilias Karagounis, Ratnesh Srivastava, Sushil Kumar, Noelle Francois, Fotis Nikolos, Igor Bado, Hann-Hsiang Chao, Constantinos Koumenis, Savitri Krishnamurthy, Naoto T Ueno, Rumela Chakrabarti, Amit Maity
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD7-02.
https://doi.org/10.1158/1538-7445.SABCS19-PD7-02
Published: 15 February 2020
View article titled, Abstract PD7-02: Estrogen receptor β suppresses metastasis of inflammatory breast cancer by regulating signaling that promotes cytoskeleton remodeling
Journal Articles

Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity

Johannes C. Melms, Sreeram Vallabhaneni, Caitlin E. Mills, Clarence Yapp, Jia-Yun Chen, Eugenio Morelli, Patricia Waszyk, Sushil Kumar, Derrick Deming, Nienke Moret, Steven Rodriguez, Kartik Subramanian, Meri Rogava, Adam N.R. Cartwright, Adrienne Luoma, Shaolin Mei, Titus J. Brinker, David M. Miller, Alexander Spektor, Dirk Schadendorf, Nicolo Riggi, Kai W. Wucherpfennig, Peter K. Sorger, Benjamin Izar
Journal: Cancer Research
Cancer Res (2020) 80 (4): 798–810.
https://doi.org/10.1158/0008-5472.CAN-19-2330
Published: 14 February 2020
View article titled, Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity
Open the PDF for Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity in another window
Includes: Multimedia, Supplementary data
Journal Articles

Abstract 1982: Sustained CXCR2 signaling promotes secretory phenotype in cancer-associated fibroblasts of pancreatic cancer via activation of NFkB

Mohammad Awaji, Michelle Varney, Abhilasha Purohit, Lingyun Wu, Sugandha Saxena, Sushil Kumar, Surinder K. Batra, Rakesh K. Singh
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1982.
https://doi.org/10.1158/1538-7445.AM2019-1982
Published: 01 July 2019
View article titled, Abstract 1982: Sustained CXCR2 signaling promotes secretory phenotype in cancer-associated fibroblasts of pancreatic cancer via activation of NFkB
Journal Articles

Abstract 2033: Bidirectional paracrine IL-33-TGF-beta signaling underlies a tumor-promoting stem cell niche

Naoki Oshimori, Sachiko Oshimori, Ajit Elhance, Justin Leitenberger, Sushil Kumar
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2033.
https://doi.org/10.1158/1538-7445.AM2019-2033
Published: 01 July 2019
View article titled, Abstract 2033: Bidirectional paracrine IL-33-TGF-beta signaling underlies a tumor-promoting stem cell niche
Journal Articles

Abstract 4438: Role of post translational modification of PAF1/PD2 in gemcitabine resistance of pancreatic cancer

Sanchita Rauth, Saswati Karmakar, Ashu Shah, Rama Krishna Nimmakayala, Rakesh Bhatia, Sakthivel Muniyan, Sushil Kumar, Samikshan Dutta, Kaustubh Datta, Surinder K. Batra, Moorthy Palanimuthu Ponnusamy
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4438.
https://doi.org/10.1158/1538-7445.AM2019-4438
Published: 01 July 2019
View article titled, Abstract 4438: Role of post translational modification of PAF1/PD2 in gemcitabine resistance of pancreatic cancer